Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BUPRENORPHINE Cause Knee arthroplasty? 51 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Knee arthroplasty have been filed in association with BUPRENORPHINE (Buprenorphine and Naloxone). This represents 0.1% of all adverse event reports for BUPRENORPHINE.

51
Reports of Knee arthroplasty with BUPRENORPHINE
0.1%
of all BUPRENORPHINE reports
36
Deaths
41
Hospitalizations

How Dangerous Is Knee arthroplasty From BUPRENORPHINE?

Of the 51 reports, 36 (70.6%) resulted in death, 41 (80.4%) required hospitalization, and 36 (70.6%) were considered life-threatening.

Is Knee arthroplasty Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BUPRENORPHINE. However, 51 reports have been filed with the FAERS database.

What Other Side Effects Does BUPRENORPHINE Cause?

Drug dependence (16,730) Overdose (13,977) Death (13,604) Toxicity to various agents (10,906) Pain (8,219) Drug withdrawal syndrome (7,149) Emotional distress (6,159) Drug abuse (4,344) Drug ineffective (4,261) Dependence (3,184)

What Other Drugs Cause Knee arthroplasty?

ADALIMUMAB (3,627) ETANERCEPT (3,541) METHOTREXATE (2,311) ABATACEPT (2,028) TOCILIZUMAB (1,881) HYDROXYCHLOROQUINE (1,828) LEFLUNOMIDE (1,771) INFLIXIMAB (1,751) TOFACITINIB (1,744) CERTOLIZUMAB PEGOL (1,731)

Which BUPRENORPHINE Alternatives Have Lower Knee arthroplasty Risk?

BUPRENORPHINE vs BUPRENORPHINE\NALOXONE BUPRENORPHINE vs BUPROPION BUPRENORPHINE vs BUPROPION HYDROBROMIDE BUPRENORPHINE vs BUPROPION\DEXTROMETHORPHAN HYDROBROMIDE BUPRENORPHINE vs BUPROPION\NALTREXONE

Related Pages

BUPRENORPHINE Full Profile All Knee arthroplasty Reports All Drugs Causing Knee arthroplasty BUPRENORPHINE Demographics